Amgen Ventures
Venture capital · San Francisco, California, United States
Also listed as Amgen
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
6Deep-tech portfolio5 active
1Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Enlaza Therapeutics
22Co-investorsShare a portfolio company
Portfolio · 6 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Enlaza Therapeutics | Biotech | Active | Sep 11, 2025 | $103.0M |
| Lyell Immunopharma | Biotech | Active | Mar 20, 2020 | $493.0M |
| Cartography Biosciences | Biotech | Active | — | — |
| DISCO Pharmaceuticals | Biotech | Active | — | — |
| Tenpoint Therapeutics | Biotech | Active | — | — |
| Armo Biosciences | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#67
Portfolio exits#160
Raises, 12 months#88
Co-investors#95
Co-investors
- Pfizer Venture InvestmentsVenture capital2 shared
- Third Rock VenturesVenture capital2 shared
- AbbVieVenture capital1 shared
- Alexandria Venture InvestmentsVenture capital1 shared
- Andreessen HorowitzVenture capital1 shared
- ARCH VentureVenture capital1 shared
- Atlas VentureVenture capital1 shared
- Avalon VenturesVenture capital1 shared
- Bessemer Venture PartnersVenture capital1 shared
- Cormorant Asset ManagementVenture capital1 shared
Sectors
- Biotech6
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.